POZ - Treatment News : New Drug May Boost HIV Treatment Effectiveness

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2009

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

April 1, 2009

New Drug May Boost HIV Treatment Effectiveness

The addition of an experimental amino acid to a standard HIV drug regimen may be all that’s necessary for people struggling to keep their viral loads undetectable, according to a study published in The Journal of Immunology and reported by EurekAlert.

Despite the potency of modern antiretroviral (ARV) treatment, it still fails to keep HIV completely under control in roughly 10 to 20 percent of people beginning treatment for the first time. Researchers have experimented with adding additional ARV drugs to typical regimens, but this strategy—called treatment intensification—comes with a good chance of additional side effects and without a guarantee of increased effectiveness.

Now, Adriano Boasso, PhD, from the Imperial College London, and his colleagues report that a modified amino acid called D-1mT increased the effectiveness of ARV treatment in monkeys infected with simian immunodeficiency virus (SIV)—the monkey version of HIV.

Boasso’s team originally theorized that D-1mT would help control SIV in monkeys regardless of whether they were given ARV treatment. This is because D-1mT is able to block an enzyme called IDO that HIV and SIV use to suppress the immune system’s attempts to control the viruses. Boasso’s team found that D-1mT had no effect at all in monkeys who were not on ARV therapy. To their surprise, however, D-1mT did help four of six monkeys who were on ARV therapy but had uncontrolled virus levels.

“The effect D-1mT seemed to have on viral load was really encouraging, but it was a surprise to us—we didn’t expect D-1mT to work only in [monkeys] that were already being treated with [ARVs],” Boasso said. “It seems that D-1mT synergizes with [ARVs], and we would really like to find out how this works.”

The authors intend to explore this effect further and to evaluate the safety of D-1mT, which is in a Phase I human study as a cancer treatment.

Search: D-1mT, IDO, amino acid, boost treatment, Adriano Boasso


Scroll down to comment on this story.

email print

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Russ, Asheville, 2009-04-03 13:28:22
Optimism is the key word here and I for 1 would participate.

Jose Villarreal, Del Rio, Tx., 2009-04-02 02:17:48
Another one of many, many failed attempts?. Go figure.

comments 1 - 2 (of 2 total)    


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar
Starting Treatment
Quilt in the Capital
POZ Army


    alphatango
    Phoenix
    Arizona


    Loveladyd
    Washington
    DC


    MascGeek
    Houston
    Texas


    robert12
    Queens
    New York
Click here to join POZ Personals!
Talk to Us
Poll
Do you support rapid in-home HIV testing?
Yes
No

Survey
Health 2.0

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.